A Genome-wide CRISPR Screen Identifies ZCCHC14 as a Host Factor Required for Hepatitis B Surface Antigen Production.

[1]  J. Young,et al.  PAPD5/7 Are Host Factors That Are Required for Hepatitis B Virus RNA Stabilization , 2019, Hepatology.

[2]  Xingchun Han,et al.  Discovery of RG7834: The First-in-Class Selective and Orally Available Small Molecule Hepatitis B Virus Expression Inhibitor with Novel Mechanism of Action. , 2018, Journal of medicinal chemistry.

[3]  V. Kim,et al.  Mixed tailing by TENT4A and TENT4B shields mRNA from rapid deadenylation , 2018, Science.

[4]  George-Lucian Moldovan,et al.  PARP10 promotes cellular proliferation and tumorigenesis by alleviating replication stress , 2018, bioRxiv.

[5]  F. Nigsch,et al.  Genome-wide CRISPR screen for PARKIN regulators reveals transcriptional repression as a determinant of mitophagy , 2017, Proceedings of the National Academy of Sciences.

[6]  Wenzhe Lu,et al.  A novel orally available small molecule that inhibits hepatitis B virus expression. , 2017, Journal of hepatology.

[7]  F. Zoulim,et al.  Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B. , 2017, Journal of hepatology.

[8]  D. Durantel,et al.  Interplay between the Hepatitis B Virus and Innate Immunity: From an Understanding to the Development of Therapeutic Concepts , 2017, Viruses.

[9]  J. Carette,et al.  A CRISPR toolbox to study virus–host interactions , 2017, Nature Reviews Microbiology.

[10]  Gregory McAllister,et al.  Identification of a novel NAMPT inhibitor by CRISPR/Cas9 chemogenomic profiling in mammalian cells , 2017, Scientific Reports.

[11]  Craig M. Crews,et al.  Induced protein degradation: an emerging drug discovery paradigm , 2016, Nature Reviews Drug Discovery.

[12]  T. Pihlajaniemi,et al.  Small-Molecule Chemical Probe Rescues Cells from Mono-ADP-Ribosyltransferase ARTD10/PARP10-Induced Apoptosis and Sensitizes Cancer Cells to DNA Damage. , 2016, Cell chemical biology.

[13]  John A. Tallarico,et al.  Functional CRISPR screening identifies the ufmylation pathway as a regulator of SQSTM1/p62 , 2016, eLife.

[14]  C. Kuny,et al.  Virus–Host Interactions and the ARTD/PARP Family of Enzymes , 2016, PLoS pathogens.

[15]  Meghan M. Holdorf,et al.  Mapping of histone modifications in episomal HBV cccDNA uncovers an unusual chromatin organization amenable to epigenetic manipulation , 2015, Proceedings of the National Academy of Sciences.

[16]  O. Hofmann,et al.  VarDict: a novel and versatile variant caller for next-generation sequencing in cancer research , 2016, Nucleic acids research.

[17]  M. Nassal.  HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B , 2015, Gut.

[18]  F. Zoulim,et al.  Antiviral therapies and prospects for a cure of chronic hepatitis B. , 2015, Cold Spring Harbor perspectives in medicine.

[19]  H. Chan,et al.  Hepatitis B virus infection , 2014, The Lancet.

[20]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[21]  Piero Carninci,et al.  PAPD5-mediated 3′ adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease , 2014, Proceedings of the National Academy of Sciences.

[22]  C. Semenkovich,et al.  Peroxisomes: a nexus for lipid metabolism and cellular signaling. , 2014, Cell metabolism.

[23]  A. Bertoletti,et al.  Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection , 2011, Gut.

[24]  Megha K. Purohit,et al.  Air1 Zinc Knuckles 4 and 5 and a Conserved IWRXY Motif Are Critical for the Function and Integrity of the Trf4/5-Air1/2-Mtr4 Polyadenylation (TRAMP) RNA Quality Control Complex* , 2011, The Journal of Biological Chemistry.

[25]  K. Borroto-Esoda,et al.  HBV DNA replication mediated by cloned patient HBV reverse transcriptase genes from HBV genotypes A-H and its use in antiviral phenotyping assays. , 2011, Journal of virological methods.

[26]  S. Hamill,et al.  Structure and function of the polymerase core of TRAMP, a RNA surveillance complex , 2010, Proceedings of the National Academy of Sciences.

[27]  R. Brodsky.  How I treat paroxysmal nocturnal hemoglobinuria. , 2009, Blood.

[28]  Cole Trapnell,et al.  Ultrafast and memory-efficient alignment of short DNA sequences to the human genome , 2009, Genome Biology.

[29]  D. Tollervey,et al.  The Many Pathways of RNA Degradation , 2009, Cell.

[30]  J. Hagman,et al.  The 'zinc knuckle' motif of Early B cell Factor is required for transcriptional activation of B cell-specific genes. , 2008, Molecular immunology.

[31]  S. Häfner,et al.  Solution structure of stem-loop α of the hepatitis B virus post-transcriptional regulatory element , 2008, Nucleic acids research.

[32]  R. König,et al.  A probability-based approach for the analysis of large-scale RNAi screens , 2007, Nature Methods.

[33]  Keith Bowman,et al.  Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs , 2005, Nature Biotechnology.

[34]  E. Petfalski,et al.  RNA Degradation by the Exosome Is Promoted by a Nuclear Polyadenylation Complex , 2005, Cell.

[35]  W. Keller,et al.  A New Yeast Poly(A) Polymerase Complex Involved in RNA Quality Control , 2005, PLoS biology.

[36]  S. Goff,et al.  Inhibition of Retroviral RNA Production by ZAP, a CCCH-Type Zinc Finger Protein , 2002, Science.

[37]  Alexander Bürkle,et al.  Increase in de novo HBV DNA integrations in response to oxidative DNA damage or inhibition of poly(ADP‐ribosyl)ation , 2002, Hepatology.

[38]  H. Tang,et al.  Transcriptional regulation of hepatitis B virus by nuclear hormone receptors is a critical determinant of viral tropism. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[39]  J. Peters,et al.  In Vivo Regulation of Hepatitis B Virus Replication by Peroxisome Proliferators , 1999, Journal of Virology.

[40]  T. Yen,et al.  Hepatitis B virus RNA element that facilitates accumulation of surface gene transcripts in the cytoplasm , 1994, Journal of virology.

[41]  T. Liang,et al.  A novel hepatitis B virus (HBV) genetic element with Rev response element-like properties that is essential for expression of HBV gene products , 1993, Molecular and cellular biology.

[42]  S. Fuller,et al.  Hepatitis B surface antigen assembles in a post-ER, pre-Golgi compartment , 1992, The Journal of cell biology.

[43]  M. Umeda,et al.  Lipid composition of hepatitis B virus surface antigen particles and the particle-producing human hepatoma cell lines. , 1990, Journal of lipid research.

[44]  D. Ganem,et al.  Sequences 5' to the polyadenylation signal mediate differential poly(A) site use in hepatitis B viruses. , 1990, Genes & development.

[45]  V. Lingappa,et al.  Secreted hepatitis B surface antigen polypeptides are derived from a transmembrane precursor , 1988, The Journal of cell biology.

[46]  A. Levinson,et al.  Analysis of processing and polyadenylation signals of the hepatitis B virus surface antigen gene by using simian virus 40-hepatitis B virus chimeric plasmids , 1983, Molecular and cellular biology.

[47]  A. Lee,et al.  HBsAg mRNA degradation induced by a dihydroquinolizinone compound depends on the HBV posttranscriptional regulatory element , 2018, Antiviral research.

[48]  Jeremy L Jenkins,et al.  Identifying compound efficacy targets in phenotypic drug discovery. , 2016, Drug discovery today.